Research
Hematology/Oncology and Bone Marrow Studies
Some of the many research opportunities available in Hematology and Oncology are listed below. Select a study to review a brief description and requirements. Parents or guardians of children who might be eligible are encouraged to inquire about enrollment. Contact information is listed at the end of each study.
Thank you for exploring these opportunities and helping us to find cures and prevent childhood disease.
Last Update
September 4, 2009- Clinical Trials
- Acute Lymphoblastic Leukemia (ALL) Relapse Study
- Acute Lymphoblastic Leukemia Study
- Acute Myeloid Leukemia (AML) Treatment Study
- Adrenal Masses in Infants
- Bevacizumab and Irinotecan Treatment Study
- Capecitabine and Radiation for Treating Brain Tumors
- Classification of Acute Lymphoblastic Leukemia
- Combination Treatment for Osteosarcoma
- Ewing Sarcoma Study
- Hepatoblastoma Risk Factors
- High Risk B-Precursor Acute Lymphoblastic Leukemia
- Hodgkin Disease Banking Study
- Immunotherapy Effectiveness for Recurrent Hodgkin's Disease
- Immunotherapy for Childhood Gliomas
- Informed Consent in Pediatric Phase I Cancer Trials
- Low-Risk Hodgkin's Disease Study
- Lymphocyte-Predominant Hodgkin Disease Study
- Nasopharyngeal Cancer Treatment Study
- National Marrow Donor Program (NMDP)
- Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia (OMA) Syndrome Treatment
- Neuroblastoma Biology Studies
- Newly Diagnosed Hodgkin Disease Study
- Non-Germinomatous Germ Cell Tumor Study
- Non-Rhabdomyosarcoma Soft Tissue Sarcomas
- Pediatric Thrombophilia Registry
- Pediatric Tumors and Specimen Study
- PEG-Intron for Plexiform Neurofibromas
- Post-Surgery Treatment of Retinoblastoma
- Post-Transplant Lymphoproliferative Disease (PTLD) Treatment
- Relapsed ALL Cell Study
- Renal Tumors Classification, Biology and Banking Study
- Research Registry for Hematology Oncology Patients
- Rhabdomyosarcoma Combination Treatment Study
- Rituximab for Treating OMS Condition
- Sickle Cell Research Registry Protocol
- Sorafenib Treatment for Recurrent Tumors and Leukemia
- Standard Risk B-Precursor Acute Lymphoblastic Leukemia
- Stem Cell Collection for Transplant Surgery
- Topotecan for Neoplastic Meningitis
- Treating GVHD with Four New Agents
- Treating Hodgkin's with Bortezomib, Ifosfamide and Vinorelbine
- Treating Idiopathic Pneumonia Syndrome (IPS) with EnbrelĀ®
- Treating Patients with Rhabdomyosarcoma
- Treating Recurrent Tumors with Sunitinib
- Treatment Development for Severe Blood Disorders
- Treatment for Low-Risk Embryonal/Botryoid Rhabdomyosarcoma
- Treatment of High-Risk Renal Tumors
- Understanding Mercaptopurine Levels
- Veno-Occlusive Disease (VOD) Study
- Vinblastine and Carboplatin for Treating Brain Tumors
- Vincristine or Vinblastine for Treating Advanced ALCL
- Wilms Tumor Treatment Study
